Today: 9 June 2026
AST SpaceMobile (ASTS) stock jumps 6% as SpaceX-xAI merger lifts U.S. space shares

AST SpaceMobile (ASTS) stock jumps 6% as SpaceX-xAI merger lifts U.S. space shares

New York, February 3, 2026, 15:01 EST — Regular session

Shares of AST SpaceMobile climbed roughly 6.3% to $111.11 by 2:46 p.m. EST Tuesday, after fluctuating between $105.82 and $116.60 earlier, with about 11.5 million shares changing hands. The stock followed a broader rally in U.S. space companies sparked by Elon Musk’s announcement that SpaceX will merge with xAI, valuing the combined entity at $1.25 trillion. Rocket Lab, Planet Labs, and Intuitive Machines also saw gains. Musk predicted that within two to three years, the most cost-effective way to power AI will be from space. Mark Boggett of Seraphim Space called the deal “the strongest validation yet that space will be the backbone of the next wave of AI.” Reuters

The jump is significant because the AI trade is spilling over into everything connected to satellites and launch gear, even if the connection is more sentiment than solid data. AST has turned into a high-beta stand-in for the “space-to-phone” concept, often tracking the sector whenever headlines drop.

“Direct-to-device” refers to satellite connections that operate on regular smartphones—no extra hardware, no special antennas needed. Investors are betting on execution: will AST launch enough capacity into orbit, and can it maintain a service stable enough for carriers and governments to commit funding?

On January 22, AST announced its BlueBird 7 satellite is set to launch in late February aboard Blue Origin’s New Glenn rocket from Launch Complex 36 at Cape Canaveral Space Force Station. “This launch advances our mission to bring space-based cellular broadband connectivity to everyday smartphones,” said Scott Wisniewski, the company’s president. He noted the timing could still change depending on readiness and weather conditions. Business Wire

The company is steering investor attention toward its defense work to broaden its narrative beyond just consumer markets. In mid-January, it secured a prime contract award under the U.S. Missile Defense Agency’s SHIELD program through an indefinite-delivery/indefinite-quantity (IDIQ) contract, which lets the agency issue task orders over time. Chris Ivory, the company’s chief commercial officer and head of government business, called the selection “a major validation.” Business Wire

Tuesday’s action felt more like a sector-wide twitch than a real change in AST’s underlying story. That’s a double-edged sword. When sentiment reverses, these shares usually retreat just as quickly.

Bears keep circling the same issues: valuation, funding requirements, and the timeline from a handful of satellites to a functional network. On January 7, Scotiabank downgraded the stock, slashing its target to $45.60. The bank labeled the valuation at the time “irrational levels,” noting the company had yet to land a retail customer, according to a report on the note. Investing.com

AST warned its launch schedule could shift and has set an ambitious pace for 2026. Any delays, launch mishaps, or weaker-than-expected initial demand would put pressure on a stock already priced for perfection.

Stock Market Today

  • Rocket Lab Stock Price Forecast: AI Analyst Cautions Despite 60% Surge
    June 9, 2026, 10:12 AM EDT. Shares of Rocket Lab USA ($RKLB) have jumped more than 60% year-to-date due to increased demand for small-satellite launches. Despite the rally, AI-driven analysis from TipRanks highlights caution, urging investors to consider potential market volatility and competitive pressures. Rocket Lab's growth taps into expanding satellite deployment, but risks remain in a crowded aerospace sector. Investors should balance optimism with these cautionary signals from advanced analytics.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers
Previous Story

Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers

Why Freeport-McMoRan Inc (FCX) stock price is up nearly 6% today
Next Story

Why Freeport-McMoRan Inc (FCX) stock price is up nearly 6% today

Go toTop